Ledger.Open graph →
SEC Form D · filed February 28, 2023

SPRUCE BIOSCIENCES, INC

Offering
$53.6M
Sold
$53.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Simpson Camilla · South San Francisco, CADirectorTiba Aynechi · South San Francisco, CADirectorDaniel Spiegelman · South San Francisco, CADirectorMichael Grey · South San Francisco, CAExec · DirectorBali Muralidhar · South San Francisco, CADirectorKirk Ways · South San Francisco, CADirectorJavier Szwarcberg · South San Francisco, CAExec · DirectorSamir Gharib · South San Francisco, CAExecJohn Mcneice · Vancouver, British Columbia, CanadaExec · DirectorMatt W. Libling · Boston, MADirectorEdmondo W. Barletta · Boston, MAExecJosh Serfass · Vancouver, British Columbia, CanadaDirectorPaul Hunter · St. Petersburg, FLDirectorChris Irwin · Vancouver, British Columbia, CanadaDirectorKimberly Ann Arntson · Vancouver, British Columbia, CanadaDirectorCarter Reginald · Dallas, TXExec · DirectorDina Chaya · SAN FRANCISCO, CADirectorRalph W. Charlton Iii · South San Francisco, CAExecOmega Strategies Energy Fund GP LLC · Dover, DEDirectorNicholas Diao · Dover, DEExec · DirectorOr-Chaim Eisenberg · Dover, DEDirectorAndrew Turner · Dover, DEExecWilliam Blair MB Investments GP, L.L.C · Chicago, ILDirectorKirsten Olsen · Chicago, ILDirectorAlexander T. Leicester · London, United KingdomDirectorVenkata Kamal Nath Devarakonda · DANVILLE, CAExec · DirectorDina Chaya · SAN FRANCISCO, CADirectorRalph W. Charlton Iii · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗